SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer receives patent for pneumonia vaccine by Indian Patent Office

23 Aug 2017 Evaluate

Pfizer has been granted patent in India by the Indian Patent Office for its vaccine Prevenar 13, used for protection against pneumonia. The grant of the patent means that Indian pharmaceutical firms will not be able to make the vaccine.

The development has, however, been decried by Medicines Sans Frontiers (MSF), an international medical humanitarian organization saying granting patent on the vaccine could impact its availability.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Pfizer Share Price

4859.50 -32.10 (-0.66%)
21-Apr-2026 12:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1220.50
Cipla 1232.75
Zydus Lifesciences 927.80
Lupin 2321.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×